New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing ...

In this episode, MM+M Pharma Editor Lecia Bushak sits down with Noom’s CEO Geoff Cook and Chief Medical Officer Dr. Jeffrey Egler to discuss the launch of their new Microdose GLP-1 program, designed ...

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic ...

"People are looking for wellness tools that work with their bodies, not against them," said Morley Baker, CEO of Shed. "With microdose GLP-1, NAD+, and Glutathione, we're giving our community ...

Online health platform Noom recently launched its Noom Microdose GLP-1 Rx Program to reportedly address barriers to GLP-1s, including medication cost. Over the last few years, the popularity of ...

Ash provides the at-home testing operational backbone for Noom’s new Proactive Health Microdose GLP-1Rx Program ...

70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss and overall health gains The program addresses all three ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Plenty of evidence shows that GLP-1 medications can help people manage type 2 diabetes and/or obesity. Drugs like Ozempic work by mimicking the hormone that releases insulin from your pancreas, ...

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Noom, the leading platform for preventive health, today announced a free tier of its acclaimed wellness app and introduced Rebel Wilson as its Chief ...

Noom CEO Geoff Cook discusses the company's move into longevity health, microdose GLP-1, and new diabetes program on 'Mornings with Maria.' ...